"AstraZeneca's CEO has stated that the pharma group is taking a China investigation 'very seriously'. The company faces scrutiny over its business practices in the country. AstraZeneca has operations and partnerships in China, which are subject to regulatory oversight."

Source: https://www.ft.com/content/ebe9d2d5-d12f-472e-a3a9-24378c41018c